Champions Oncology, Inc. (CSBR)
4.71
-0.08
(-1.67%)
USD |
NASDAQ |
Oct 16, 14:58
Champions Oncology SG&A Expense (TTM) : 21.81M for July 31, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| July 31, 2026 | 21.81M |
| April 30, 2026 | 20.47M |
| January 31, 2026 | 19.87M |
| October 31, 2025 | 18.44M |
| July 31, 2025 | 17.10M |
| April 30, 2025 | 16.88M |
| January 31, 2025 | 16.59M |
| October 31, 2024 | 16.94M |
| July 31, 2024 | 17.70M |
| April 30, 2024 | 18.13M |
| January 31, 2024 | 18.19M |
| October 31, 2023 | 17.96M |
| July 31, 2023 | 17.79M |
| April 30, 2023 | 17.24M |
| January 31, 2023 | 17.02M |
| October 31, 2022 | 16.47M |
| July 31, 2022 | 15.86M |
| April 30, 2022 | 15.50M |
| January 31, 2022 | 14.42M |
| October 31, 2021 | 13.97M |
| July 31, 2021 | 13.17M |
| April 30, 2021 | 12.03M |
| January 31, 2021 | 12.32M |
| October 31, 2020 | 11.85M |
| July 31, 2020 | 11.15M |
| Date | Value |
|---|---|
| April 30, 2020 | 10.86M |
| January 31, 2020 | 9.556M |
| October 31, 2019 | 8.795M |
| July 31, 2019 | 8.457M |
| April 30, 2019 | 7.734M |
| January 31, 2019 | 7.052M |
| October 31, 2018 | 6.581M |
| July 31, 2018 | 6.312M |
| April 30, 2018 | 6.631M |
| January 31, 2018 | 7.49M |
| October 31, 2017 | 7.421M |
| July 31, 2017 | 7.655M |
| April 30, 2017 | 8.222M |
| January 31, 2017 | 7.628M |
| October 31, 2016 | 7.886M |
| July 31, 2016 | 8.681M |
| April 30, 2016 | 8.568M |
| January 31, 2016 | 9.039M |
| October 31, 2015 | 9.399M |
| July 31, 2015 | 9.445M |
| April 30, 2015 | 9.595M |
| January 31, 2015 | 9.902M |
| October 31, 2014 | 10.66M |
| July 31, 2014 | 10.06M |
| April 30, 2014 | 9.277M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Medpace Holdings, Inc. | 189.02M |
| Avantor, Inc. | 1.599B |
| Personalis, Inc. | 67.03M |
| Adaptive Biotechnologies Corp. | 180.38M |
| 10X Genomics, Inc. | 297.01M |